Uropathogenic bacteria leave a mark

Laboratory Investigation

Volumn 91, Issue 6, 2011, Pages 816-818

  Schulz, Wolfgang A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

DNA methylation; epigenetics; urinary tract infection; uropathogenic E. coli; urothelium

Indexed keywords

CDKN2 PROTEIN; DNA METHYLTRANSFERASE 1; PROTEIN; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BACTERIUM; CANCER CELL CULTURE; CARCINOGENESIS; EPIGENETICS; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; METHYLATION; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; URINARY TRACT INFECTION; UROTHELIUM;

CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FIMBRIAE, BACTERIAL; GENE EXPRESSION REGULATION; GENES, P16; HOST-PATHOGEN INTERACTIONS; HUMANS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 79957622522     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.51     Document Type: Review

References (20)

1. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol 2010;7:653-660.
2. Song J, Abraham SN. Innate and adaptive immune responses in the urinary tract. Eur J Clin Invest 2008;38(Suppl 2):21-28.
3. Weichhart T, Haidinger M, Hö rl WH, et al. Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur J Clin Invest 2008;38(Suppl 2):29-38.
4. Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol 2008;85:11-19.
5. Dhakal BK, Kulesus RR, Mulvey MA. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest 2008;38(Suppl 2):2-11.
6. Svanborg C, Bergsten G, Fischer H, et al. Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol 2006;9:33-39. (Pubitemid 43184335)
7. Hannan TJ, Mysorekar IU, Hung CS, et al. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 2010;6.
8. Ashkar AA, Mossman KL, Coombes BK, et al. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog 2008;4:e1000233.
9. Ragnarsdó ttir B, Jö nsson K, Urbano A, et al. Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PloS One 2010;5:e10734.
10. Tolg C, Sabha N, Cortese R, et al. Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. Lab Invest 2011;91:825-836 (this issue).
11. Tomlinson DC, Lamont FR, Shnyder SD, et al. Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer. Cancer Res 2009;69:4613-4620.
12. Varley CL, Southgate J. Organotypic and 3D reconstructed cultures of the human bladder and urinary tract. Methods Mol Biol 2011;695:197-211.
13. Minárovits J. Microbe-induced epigenetic alterations in host cells: the coming era of patho-epigenetics of microbial infections. A review. Acta Microbiol Immunol Hung 2009;56:1-19.
14. Ding SZ, Goldberg JB, Hatakeyama M. Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. Future Oncol 2010;6:851-862.
15. Sepulveda AR, Yao Y, Yan W, et al. CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology 2010;138:1836-1844.
16. Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 2007;25:285-295.
17. Wu X, Ros MM, Gu J, et al. Epidemiology and genetic susceptibility to bladder cancer. BJU Int 2008;102: 1207-1215.
18. Abol-Enein H. Infection: is it a cause of bladder cancer? Scand J Urol Nephrol Suppl 2008;218:79-84.
19. Gutiérrez MI, Siraj AK, Khaled H, et al. CpG island methylation in Schistosoma- and non-Schistosomaassociated bladder cancer. Mod Pathol 2004;17: 1268-1274. (Pubitemid 39312953)
20. Florl AR, Franke KH, Niederacher D, et al. DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder. Lab Invest 2000;80:1513-1522.